Asia Pacific Urinalysis Market

Market Introduction

APAC consists of five major countries namely China, Japan, India, Australia, and South Korea. The market is also evaluated for the rest of countries in APAC. The market is driven by the factors such as increasing incidences of chronic diseases such as diabetes, kidney disorder and liver diseases, growing strategic developments in urinalysis market, and growing development for healthcare facilities that demand advanced urinalysis analyzers for accurate and precise diagnosis. Moreover, growing geriatric population in the region, and increasing number of diagnostic laboratories in this region will support the market growth during the forecast period.

The COVID-19 pandemic affected most programs in APAC, but to varying degrees. Medical device manufacturers and suppliers are shifting their focus on supplying essentials and medical devices related to the management of COVID-19. The shift in focus toward pandemic has disrupted the spectrum of kidney and renal care, including delayed diagnoses and treatment, and disrupted clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients receive essential care while minimizing exposure to SARS-CoV-2 infection. Diagnostic testing service providers are coordinating with healthcare authorities to manage testing services residues, prioritize testing services, and use modern technology to overcome potential barriers. The increased adoption of at-home settings for urinalysis for the diagnosis of diseases such as UTIs, and other renal and kidney diseases tests also helped fill the gaps in screening. The transport restrictions imposed by various countries have had a major influence on international trade and commerce. India, too, has suffered owing to unexpected economic disruptions caused by interim restrictions on public activities and regional lockdowns. Asia’s value chains have closely integrated the economies of China, Japan, South Korea, Hong Kong, and other Asian countries. Such dense and extremely coordinated value chains enable massive economies of scale in manufacturing.     

Market Overview and Dynamics

The urinalysis market in APAC is expected to grow from US$ 917.20 million in 2021 to US$ 1,411.47 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The rest of the APAC region includes Thailand, New Zealand, Singapore, Myanmar, Vietnam, and Hong Kong. The countries are developing fastest in terms of healthcare infrastructure that are involved in the rapid technological developments in diagnostic procedures and increasing trend of medical tourism in these countries due to cost effective medical procedures will support the development of urinalysis market. For instance, Sysmex Thailand a leading provider of automated urinalysis solutions, has received ISO 9001:2015 certification to sale, distribute, and install clinical diagnostic equipment in laboratories, hospitals, and healthcare organizations. Moreover, according to report published in MDPI journal of pharmaceutics in 2020, Malaysia has been ranked as the highest diabetes cases recorded in Asia, with around 3.6 million patients. By 2025, it is expected that around seven million adults will suffer from diabetes. Therefore, increasing screening of diabetes and other non-communicable as well as infectious diseases might provide significant growth opportunities for urinalysis market in rest of the APAC region during the forecast period.

Key Market Segments

APAC urinalysis market is segmented into product, test type, application, end user, and country. Based on product, the APAC urinalysis market is segmented into consumables and instruments. The consumables segment is expected to hold a larger market share in 2021. The APAC urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment would hold the largest share of the market in 2021. Based on application, the APAC urinalysis market is segmented into disease screening and pregnancy, and fertility. The disease screening segment would account for a larger market share in 2021. The APAC urinalysis market, by end user, is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021. Based on country, the APAC urinalysis market is segmented into Australia, China, India, Japan, South Korea, and rest of APAC. China held the largest market share in 2021.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the urinalysis market in APAC are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; ACON Laboratories, Inc.; ARKRAY, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories Inc.; Cardinal Health Inc; F. Hoffmann-La Roche Ltd.; Quidel Corporation; Siemens Healthineers AG; and Sysmex Corporation.         

Reasons to buy report

• To understand the APAC urinalysis market landscape and identify market segments that are most likely to guarantee a strong return.
• Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC urinalysis market.
• Efficiently plan M&A and partnership deals in APAC urinalysis market by identifying market segments with the most promising probable sales.
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC urinalysis market.
• Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.

APAC Urinalysis Market Segmentation

APAC Urinalysis Market - By Product

• Consumables
• Instruments

APAC Urinalysis Market - By Test Type

• Pregnancy and Fertility Tests
• Biochemical Urinalysis
• Sediment Urinalysis

APAC Urinalysis Market - By Application

• Disease Screening
• Pregnancy and Fertility

APAC Urinalysis Market - By End User

• Hospitals and Clinics
• Diagnostic Laboratories
• Home Care Settings
• Research Laboratories and Institutes

APAC Urinalysis Market - By Country

• Australia
• China
• India
• Japan
• South Korea
• Rest of APAC

APAC Urinalysis Market - Company Profiles

• Abbott    
• ACON Laboratories, Inc.             
• ARKRAY, Inc.     
• Beckman Coulter, Inc.     
• Bio-Rad Laboratories Inc.            
• Cardinal Health Inc         
• F. Hoffmann-La Roche Ltd.          
• Quidel Corporation          
• Siemens Healthineers AG           
• Sysmex Corporation

Asia Pacific Urinalysis Market Strategic Insights

Asia Pacific UrinalysisMarket Report Highlights

Asia Pacific Urinalysis Market Country and Regional Insights